Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.

Autor: Inomata, Minehiko1 (AUTHOR) 9446-tym@umin.org, Tsuda, Takeshi2 (AUTHOR), Ichikawa, Tomomi3 (AUTHOR), Matsumoto, Masahiro1 (AUTHOR), Mizushima, Isami3 (AUTHOR), Azechi, Kenji2 (AUTHOR), Takata, Naoki2 (AUTHOR), Murayama, Nozomu3 (AUTHOR), Hayashi, Kana1 (AUTHOR), Hirai, Takahiro1 (AUTHOR), Seto, Zenta1 (AUTHOR), Tokui, Kotaro1 (AUTHOR), Masaki, Yasuaki2 (AUTHOR), Taka, Chihiro1 (AUTHOR), Okazawa, Seisuke1 (AUTHOR), Kambara, Kenta1 (AUTHOR), Imanishi, Shingo1 (AUTHOR), Taniguchi, Hirokazu2 (AUTHOR), Miwa, Toshiro1 (AUTHOR), Hayashi, Ryuji4 (AUTHOR)
Zdroj: Thoracic Cancer. Jun2023, Vol. 14 Issue 17, p1618-1623. 6p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje